Illinois Administrative Code
Title 77 - PUBLIC HEALTH
Part 2085 - RESEARCH
- Section 2085.10 - Definitions
- Section 2085.15 - Eligibility
- Section 2085.20 - Authorization Procedure
- Section 2085.25 - Terms and Conditions of Authorization
- Section 2085.30 - Informed Consent
- Section 2085.35 - Research Order Blanks for Dispensing Delta-9-THC Capsules
- Section 2085.40 - Labeling Requirements
- Section 2085.45 - Packaging Requirements
- Section 2085.50 - Confidentiality of Cancer Chemotherapy Patients Receiving delta-9-THC Medication
- Section 2085.55 - Reports and Recordkeeping
- Section 2085.60 - Audits and Inspections
- Section 2085.65 - Security
- Exhibit A - DAS Form 229-1
- Exhibit B - DASA Form 229-2
- Exhibit C - Special Instructions overing Research Medication Order Forms for Delta-9-Tetrahydrocannabinol
- Exhibit D - Special Instructions Covering Research Medication Labels for Delta-9-Tetrahydrocannabinol Containers
- Exhibit E - Research Order for Delta-9-Tetrahydrocannabinol
Current through Register Vol. 47, No. 52, December 29, 2023
Adopted at 5 Ill. Reg. 4868, effective April 22, 1981; transferred July 1, 1984 to the Department of Alcoholism and Substance Abuse by the Alcoholism and substance Abuse Act; codified at 8 Ill. Reg. 19340; recodified from Department of Alcoholism and Substance Abuse to Department of Human Services at 21 Ill. Reg. 9319.
AUTHORITY: Implementing and authorized by Section 11 of the Cannabis Control Act [720 ILCS 550/11 ].
Disclaimer: These regulations may not be the most recent version. Illinois may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.